Our team always customizes your treatment to your needs, but rare sensitivities can still occur, leading to nausea, weakness, or malaise
SGLT-2 inhibitors and GLP-1RA should, therefore, be considered evidence-based treatments for patients with type 2 diabetes after metformin
GLP-1 (glucagon-like-peptide-1), a receptor agonist, which means that it mimics the hormone GLP-1 known for regulating hunger (and therefore food intake)
Initial clinical evidence suggests that GLP-1s may help in three key areas: 1
Safe and Responsible Peptide Distribution: To ensure the proper and safe use of research peptides, Limitless Life makes it clear on their website that their products are intended for research use
This precision-based approach supports more informed clinical decisions